BSE filing, NSE: ALIVUS. Summary written from the filing by ALFA Finder's alert engine.
Alivus Life Sciences Ltd: key numbers
- Share price
- ₹1,393.90
- Market cap
- ₹17,113 Cr
- Revenue (annual)
- ₹2,552 Cr
- Net profit (annual)
- ₹564.5 Cr
- P/E (TTM)
- 28.4×Sector 46.1×
- Promoter holding
- 74.85%-0.02% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alivus Life Sciences Ltd
All →Alivus Life Sciences Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Alivus Life Sciences Legal & Regulatory
Alivus Life Sciences Limited received a GST order for FY 2020-22 involving a tax demand and penalty of Rs. 0.51 Crore. The company is currently assessing an appeal.
- Value
- ₹0.51 Cr
Alivus Life Sciences Acquisition Worth ₹14.04 Cr
Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited for Rs. 14.04 Crore. The investment supports its renewable energy and carbon neutrality goals.
- Value
- ₹14.04 Cr
Alivus Life Sciences Merger & Restructuring Worth ₹0.9 Cr
Alivus Life Sciences incorporated a wholly owned pharma subsidiary in Brazil. The company subscribes up to R$500,000 (₹0.90 Cr) for 100% of the new entity.
- Value
- ₹0.90 Cr
Alivus Life Sciences Annual General Meeting
Alivus Life Sciences Limited successfully conducted its 15th Annual General Meeting on September 8, 2026. All resolutions proposed in the AGM notice were passed with requisite majority.
Alivus Life Sciences Merger & Restructuring Worth ₹9.12 Cr
Alivus Life Sciences Limited will acquire a 76% stake in IQGEN-X Pharma Private Limited for approximately ₹9.12 Crore. This strategic acquisition enhances the company's CDMO solution offerings.
- Value
- ₹9.12 Cr
Other board meeting date announcements
All →Jattashankar Industries Board Meeting Date
Jattashankar Industries will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results are announced.
Aptech Board Meeting Date
Aptech will hold a board meeting on November 4, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after the results are declared.
McNally Bharat Engineering Company Board Meeting Date
McNally Bharat will hold a board meeting on November 12, 2026 to approve unaudited September quarter results. The trading window stays closed until 48 hours after submission.
Shiprocket Board Meeting Date
Shiprocket will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed until 48 hours after the outcome is declared.
Seamec Board Meeting Date
Seamec's board meets on 3 November 2026 to consider unaudited quarterly results. The results are not yet approved.
S P Capital Financing Board Meeting Date
SP Capital Financing will hold a board meeting on 4 November 2026 to consider Q2 and half-year results and an interim dividend. The record date for the interim dividend is 13 November 2026.